Legend BiotechCorp Profitability Analysis

Stocks . USA . 
Stock . Legend BiotechCorp
LEGN Stock  USD 63.62  0.55  0.86%   
For Legend BiotechCorp profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Legend BiotechCorp to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Legend BiotechCorp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Legend BiotechCorp's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Legend BiotechCorp over time as well as its relative position and ranking within its peers. Check out Correlation Analysis. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.
  
Legend BiotechCorp Price to Sales Ratio is very stable at the moment as compared to the past year. Legend BiotechCorp reported last year Price to Sales Ratio of 67.86. As of 1st of June 2023, Sales per Share is likely to grow to 0.75, while Return on Sales is likely to drop (4.01) . As of 1st of June 2023, Income Tax Expense is likely to grow to about 674.3 K, while Consolidated Income is likely to drop (458.1 M).

Legend BiotechCorp Revenues

104.42 Million

Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.14) 
Revenue Per Share
0.639
Quarterly Revenue Growth
(0.12) 
Return On Assets
(0.29) 
Return On Equity
(0.96) 
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party. Check out Correlation Analysis. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.

Legend BiotechCorp Debt to Equity vs. Total Asset Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Legend BiotechCorp's current stock value. Our valuation model uses many indicators to compare Legend BiotechCorp value to that of its competitors to determine the firm's financial worth.
Legend BiotechCorp is currently regarded as number one stock in total asset category among related companies. It is currently regarded as number one stock in debt to equity category among related companies . The ratio of Total Asset to Debt to Equity for Legend BiotechCorp is about  4,527,085,034 . As of 1st of June 2023, Debt to Equity Ratio is likely to grow to 0.81. Also, Average Equity is likely to grow to about 814.7 M. Comparative valuation analysis is a catch-all model that can be used if you cannot value Legend BiotechCorp by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Legend BiotechCorp's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Legend BiotechCorp's earnings, one of the primary drivers of an investment's value.

Legend Debt to Equity vs. Total Asset

Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Legend BiotechCorp 
Total Asset 
 = 
Tangible Assets 
+ 
Intangible Assets 
 = 
1.33 B
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Legend BiotechCorp 
D/E 
 = 
Total Debt 
Total Equity 
 = 
0.29 %
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.

Legend Debt to Equity Comparison

Legend BiotechCorp is currently under evaluation in debt to equity category among related companies.

Legend BiotechCorp Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Legend BiotechCorp, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Legend BiotechCorp will eventually generate negative long term returns. The profitability progress is the general direction of Legend BiotechCorp's change in net profit over the period of time. It can combine multiple indicators of Legend BiotechCorp, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for 2023
Consolidated Income-446.3 M-458.1 M
Net Income-446.3 M-458.1 M
Net Income Common Stock-446.3 M-458.1 M
Operating Income-446 M-457.7 M
Income Tax Expense625 K674.3 K

Legend Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Legend BiotechCorp. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Legend BiotechCorp position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Legend BiotechCorp's important profitability drivers and their relationship over time.
Revenue vs Total Asset
Return On Equity vs Market Capitalization
Revenue vs Working Capital
Cash and Equivalents vs Market Capitalization
Revenue vs Cash per Share
Return On Asset vs Market Capitalization
Revenue vs Cash Flow from Operations
Shares Owned by Institutions vs Market Capitalization
Revenue vs Current Valuation
Net Income vs Market Capitalization
Revenue vs Current Ratio
Total Debt vs Market Capitalization
Revenue vs Beta
Earnings Per Share vs Market Capitalization
Revenue vs Short Ratio

Legend BiotechCorp Profitability Trends

Legend BiotechCorp profitability trend refers to the progression of profit or loss within a business. An upward trend means that Legend BiotechCorp's profit has generally increased over time, and a downward profitability trend means profits are declining. Recognizing problems early in profitability trends allows investors to address revenue and cost issues in advance. Investors and analysts usually monitor three types of profitability trends: gross, operating, and net. Gross profit is the difference between revenue and costs of goods sold. Operating profit is Legend BiotechCorp's gross profit minus its overhead. After you account for other unusual revenue, expenses, and costs, you get net profit. Gross profit trends are often a good indicator of future profitability. If you have high gross profit margins, you have a better chance to cover overhead and make money.

Legend BiotechCorp Profitability Drivers Correlations

One of the toughest challenges investors face today is learning how to quickly synthesize and read into endless financial statements and information provided by the company, SEC reporting, and various external parties. Understanding the correlation between Legend BiotechCorp different financial indicators related to revenue and profit generation helps investors identify and prioritize their investing strategies towards Legend BiotechCorp in a much-optimized way. Analyzing correlations between profit drivers that are directly associated with dollar figures is the most effective way to break down Legend BiotechCorp's future profitability.
Click cells to compare fundamentals

Use Legend BiotechCorp in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Legend BiotechCorp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Legend BiotechCorp will appreciate offsetting losses from the drop in the long position's value.

Legend BiotechCorp Pair Trading

Legend BiotechCorp Pair Trading Analysis

The ability to find closely correlated positions to Legend BiotechCorp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Legend BiotechCorp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Legend BiotechCorp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Legend BiotechCorp to buy it.
The correlation of Legend BiotechCorp is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Legend BiotechCorp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Legend BiotechCorp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Legend BiotechCorp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Legend BiotechCorp position

In addition to having Legend BiotechCorp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run World Allocation Thematic Idea Now

World Allocation
World Allocation Theme
Funds or Etfs investing in stocks, bonds, and cash of domestic markets as well as in markets of Canada, Japan, and Europe. The World Allocation theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize World Allocation Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide. Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Complementary Tools for Legend Stock analysis

When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Bond Directory
Find actively traded corporate debentures issued by US companies
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
To fully project Legend BiotechCorp's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Legend BiotechCorp at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Legend BiotechCorp's income statement, its balance sheet, and the statement of cash flows.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Financial
Indicators
Details
Valuation
Indicators
Details
Potential Legend BiotechCorp investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Legend BiotechCorp investors may work on each financial statement separately, they are all related. The changes in Legend BiotechCorp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Legend BiotechCorp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2023 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY